Rateau-Matton S, Ansoborlo E, Hodgson A
Laboratoire de Radiotoxicologie, CEA/DSV/DRR/SRCA/LRT, BP n 12, 91680 Bruyères-Le-Châtel, France.
Int J Radiat Biol. 2004 Oct;80(10):777-85. doi: 10.1080/09553000400017978.
To compare specific absorption parameter values obtained from in vitro dissolution studies (this paper) and in vivo experiments (data published by Ramounet et al, 2000) and to determine their influence on Dose Per Unit Intake (DPUI) calculations.
Experiments were performed on plutonium oxide (PuO2) and two Mixed Oxide (MOx) preparations containing 5% Pu (w/w) made according to the industrial process in vitro using a static test and in vivo after rat inhalation.
Behaviour of Pu and Am shows, in vitro, at shorter times, a greater rapid dissolution fraction f(r) for Pu (factor 10) and Am (factor 2) with MOx powders compared with PuO2, whereas in vivo results show a greater fraction f(r) for Pu (factor 5) and Am (factor 15) with PuO2 compared with MOx powders. This phenomenon has not been observed for slow dissolution absorption parameter s(s). The in vivo parameters for Pu and Am in these materials were very close to the default values recommended by International Commission for Radiological Protection for default Type S.
Results obtained have shown that solubility of Pu from the mixed oxide was higher than that of Pu from PuO2. Nevertheless, no significant difference was observed between the three compounds in the corresponding dose coefficients in vivo or in vitro. Therefore, for these particular compounds, variation in the chemical composition of the aerosols had no significant influence on DPUI. Consequently, in vitro, the dissolution test can provide a good estimate of the in vivo behaviour. Studies of variation of % Pu (w/w) from MOx are in progress in our laboratory to confirm these conclusions.
比较体外溶解研究(本文)和体内实验(Ramounet等人于2000年发表的数据)获得的比吸收参数值,并确定它们对单位摄入量剂量(DPUI)计算的影响。
对氧化钚(PuO2)和两种含5%钚(重量/重量)的混合氧化物(MOx)制剂进行实验,这两种制剂是按照工业流程在体外使用静态试验制备的,并在大鼠吸入后进行体内实验。
钚和镅的行为表明,在体外较短时间内,与PuO2相比,MOx粉末中钚(系数为10)和镅(系数为2)的快速溶解分数f(r)更大,而在体内结果中,与MOx粉末相比,PuO2中钚(系数为5)和镅(系数为15)的f(r)更大。对于缓慢溶解吸收参数s(s),未观察到这种现象。这些材料中钚和镅的体内参数非常接近国际放射防护委员会推荐的默认S型默认值。
获得的结果表明,混合氧化物中钚的溶解度高于PuO2中钚的溶解度。然而,在体内或体外,这三种化合物的相应剂量系数之间未观察到显著差异。因此,对于这些特定化合物,气溶胶化学成分的变化对DPUI没有显著影响。因此,在体外,溶解试验可以很好地估计体内行为。我们实验室正在进行关于MOx中钚含量百分比(重量/重量)变化的研究,以证实这些结论。